Dysregulation of m6A regulators, including the upregulation of METTL3 and the downregulation of YTHDF2, has been linked to the activation of TGF-β signaling pathways and the subsequent development of renal fibrosis in CKD. Here, METTL3 is linked to chronic kidney disease.